BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27242953)

  • 21. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.
    Smith BAH; Bertozzi CR
    Nat Rev Drug Discov; 2021 Mar; 20(3):217-243. PubMed ID: 33462432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the glycan toolbox for pathogenic interventions and glycan immunotherapy.
    Li RE; van Vliet SJ; van Kooyk Y
    Curr Opin Biotechnol; 2018 Jun; 51():24-31. PubMed ID: 29175707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation.
    Mendez-Huergo SP; Maller SM; Farez MF; Mariño K; Correale J; Rabinovich GA
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):247-55. PubMed ID: 24684768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
    Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
    Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensing Glycans as Biochemical Messages by Tissue Lectins: The Sugar Code at Work in Vascular Biology.
    Kaltner H; Gabius HJ
    Thromb Haemost; 2019 Apr; 119(4):517-533. PubMed ID: 30620995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in understanding and exploiting Siglec-glycan interactions.
    Jame-Chenarboo Z; Gray TE; Macauley MS
    Curr Opin Chem Biol; 2024 Jun; 80():102454. PubMed ID: 38631213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
    Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
    Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-Binding O-Glycosylations as Regulators of Malignancy.
    Dimitroff CJ
    Cancer Res; 2015 Aug; 75(16):3195-202. PubMed ID: 26224120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.
    Lübbers J; Rodríguez E; van Kooyk Y
    Front Immunol; 2018; 9():2807. PubMed ID: 30581432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological modulation by lectins and their ligands in tumor progression and metastasis.
    Nakahara S; Raz A
    Anticancer Agents Med Chem; 2008 Jan; 8(1):22-36. PubMed ID: 18220503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Blessed Union of Glycobiology and Immunology: A Marriage That Worked.
    Dos Reis JS; Diniz-Lima I; Santos MARDC; Barcelos PM; da Costa KM; Valente RDC; Chaves LS; de Campos LP; Dos Santos AC; Correia de Lima RG; Decote-Ricardo D; Morrot A; Previato JO; Mendonça-Previato L; Freire-de-Lima CG; Fonseca LMD; Freire-de-Lima L
    Medicines (Basel); 2023 Jan; 10(2):. PubMed ID: 36827215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity.
    Dam TK; Brewer CF
    Glycobiology; 2010 Mar; 20(3):270-9. PubMed ID: 19939826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins.
    Bax M; García-Vallejo JJ; Jang-Lee J; North SJ; Gilmartin TJ; Hernández G; Crocker PR; Leffler H; Head SR; Haslam SM; Dell A; van Kooyk Y
    J Immunol; 2007 Dec; 179(12):8216-24. PubMed ID: 18056365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation.
    Bochner BS; Zimmermann N
    J Allergy Clin Immunol; 2015 Mar; 135(3):598-608. PubMed ID: 25592986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet.
    Hockl PF; Wolosiuk A; Pérez-Sáez JM; Bordoni AV; Croci DO; Toum-Terrones Y; Soler-Illia GJ; Rabinovich GA
    Pharmacol Res; 2016 Jul; 109():45-54. PubMed ID: 26855319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycobiology of immune responses.
    Rabinovich GA; van Kooyk Y; Cobb BA
    Ann N Y Acad Sci; 2012 Apr; 1253():1-15. PubMed ID: 22524422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terminal Epitope-Dependent Branch Preference of Siglecs Toward
    Wang S; Chen C; Guan M; Liu D; Wan XF; Li L
    Front Mol Biosci; 2021; 8():645999. PubMed ID: 33996901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface glycan-lectin interactions in tumor metastasis.
    Rambaruth ND; Dwek MV
    Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.